CPXM2 and hypertensive disorder: Only Cpxm2 was confirmed in validation experiments because it demonstrated consistent and significant differential expression between the SHRSP and SHSRP-1F344 strains in separate qPCR expression analysis of LV tissue in adult and young rats at 4 and 8 weeks of age without established hypertension (Supplementary Fig. 3).